Corporate News     12-Jun-20
Caplin Steriles receives USFDA final approval for Phenylephrine Hydrochloride injection
Caplin Point Laboratories announced that its subsidiary, Caplin Steriles has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Phenylephrine Hydrochloride injection USP, 10 mg/mL Single-Dose Vial, 50 mg/5 mL (10mg/mL) Pharmacy Bulk Package, and 100 mg/10 mL (10 mg/mL) Pharmacy Bulk Package, a generic therapeutic equivalent version of (RLD), VAZCULEP Injection, of Avadel Legacy Pharmaceuticals LLC.

According to IQVIATM (IMS Health), Phenylephrine Hydrochloride injection USP had US sales data of approximately $45 million for the 12-month period ending Mar 2020. Caplin Steriles Limited, has developed and filed 17 ANDAs on its own and with partners, with 9 approvals so far.

Phenylephrine Hydrochloride injection is indicated for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia.

Previous News
  Caplin Point Laboratories receives INVIMA approval for Softgel Capsules division at Puducherry
 ( Corporate News - 06-May-24   14:53 )
  Caplin signs MoU with Govt. of Tamil Nadu
 ( Corporate News - 08-Jan-24   17:55 )
  Caplin Point rises on USFDA nod for eye drops
 ( Hot Pursuit - 16-Apr-24   11:02 )
  Caplin Point jumps after Q3 PAT rises 30% YoY to Rs 120 cr
 ( Hot Pursuit - 12-Feb-24   12:46 )
  Caplin Point Laboratories announces board meeting date
 ( Corporate News - 10-May-24   11:22 )
  Caplin Steriles receives USFDA approval for Ofloxacin Otic Solution
 ( Corporate News - 08-Jan-24   15:15 )
  Caplin Steriles receives USFDA approval for Ofloxacin Ophthalmic Solution USP 0.3%
 ( Corporate News - 16-Apr-24   11:32 )
  Caplin Point Laboratories fixes record date for final dividend
 ( Market Beat - Reports 05-Sep-22   12:58 )
  Caplin Point Laboratories consolidated net profit rises 30.06% in the December 2022 quarter
 ( Results - Announcements 11-Feb-23   15:15 )
  Caplin Point Laboratories allots 91,704 equity shares under ESOP
 ( Corporate News - 15-Dec-22   12:51 )
  Board of Caplin Point Laboratories recommends interim dividend
 ( Corporate News - 13-May-22   09:58 )
Other Stories
  PVV Infra to convene board meeting
  05-Oct-24   10:06
  Avenue Supermarts declare Quarterly Result
  05-Oct-24   10:06
  Fortis Healthcare to hold board meeting
  05-Oct-24   10:06
  Syngene International to convene board meeting
  05-Oct-24   10:06
  Srestha Finvest to conduct board meeting
  05-Oct-24   10:06
  Spright Agro schedules board meeting
  05-Oct-24   10:05
  Jagsonpal Finance & Leasing to table results
  05-Oct-24   10:05
  Hathway Cable & Datacom to hold board meeting
  05-Oct-24   10:05
  Bajaj Housing Finance to announce Quarterly Result
  05-Oct-24   10:05
  Board of NRB Bearings recommends interim dividend
  05-Oct-24   09:27
Back Top